Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S12 pseudogene 26 (RPS12P26) is a processed pseudogene in the human genome, related by sequence to the functional RPS12 gene. Pseudogenes originate from gene duplication or retrotransposition events and generally do not produce functional proteins. RPS12P26 is not known to be expressed or to have a biological role. The canonical RPS12 protein is a cytoplasmic component of the 40S ribosomal subunit, but pseudogenes like RPS12P26 do not contribute to ribosome structure or function. Genomic studies note that ribosomal protein genes are often accompanied by numerous pseudogenes dispersed throughout the genome. Pseudogenes typically lack therapeutic relevance and are not generally the focus of biomarker or drug development pipelines. Pseudogene nomenclature (such as “RPS12P26”) is standardized to distinguish these sequences from functional genes. No structured data links RPS12P26 to any therapeutically relevant pathway, protein interaction, or disease biology. If you are searching for a therapeutic target, you likely want the functional Ribosomal protein S12 (gene: RPS12), not this pseudogene copy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S12 pseudogene 26 (RPS12P26).